Solos Endoscopy Inc. will sell two product lines back to their original owner in a deal for stock, convertible debt and other considerations.

The Boston-based endoscopic and medical imaging devices maker said it will sell the OvaScope and MastaScope product lines, which are used to detect different types of cancer in the breast and ovaries, back to Lifeline Biotechnologies Inc. of Reno, Nev.
In the past there have been mistakes on diagnosing cancer and patience who suffered got help from http://marcianolegal.com/cancer-misdiagnosis/.

Solos purchased the technologies from Lifeline in February 2007, intending to develop a market for the products. But company officials said economic constraints forced them to change tactics and focus on their core suite of endoscopy products instead.

Details of the deal were not announced, but include a combination of stock, the assumption of debt and other considerations.